Neuroscience

Study unlocks mystery of dystonia with advanced imaging

An estimated 300,000 people in North America are afflicted with dystonia, a disorder characterized by a progressive loss of motor control. Patients with generalized dystonia grapple with involuntary muscle spasms that lead ...

Medications

FDA panel unanimously votes down Parkinson's drug

A panel of federal medical specialists has unanimously voted that a drug for Parkinson's disease from Teva Pharmaceuticals has not been shown to slow progress of the debilitating neurological disease.

Neuroscience

Brain stimulator shown to reduce 'untreatable' epileptic seizures

Brain stimulation, already approved by the U.S. Food and Drug Administration for the treatment of Parkinson's disease and essential tremor, has now been shown to offer significant relief to patients with intractable seizures ...

page 3 from 8